These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 30610611)

  • 1. Adenosine A
    Aso E; Fernández-Dueñas V; López-Cano M; Taura J; Watanabe M; Ferrer I; Luján R; Ciruela F
    Mol Neurobiol; 2019 Aug; 56(8):5382-5391. PubMed ID: 30610611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the Adenosine 2A Receptor to Behavioral Effects of Tetrahydrocannabinol, Cannabidiol and PECS-101.
    Stollenwerk TM; Pollock S; Hillard CJ
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice.
    Myers AM; Siegele PB; Foss JD; Tuma RF; Ward SJ
    Br J Pharmacol; 2019 May; 176(10):1552-1567. PubMed ID: 29338068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors.
    Viñals X; Moreno E; Lanfumey L; Cordomí A; Pastor A; de La Torre R; Gasperini P; Navarro G; Howell LA; Pardo L; Lluís C; Canela EI; McCormick PJ; Maldonado R; Robledo P
    PLoS Biol; 2015 Jul; 13(7):e1002194. PubMed ID: 26158621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Singular Location and Signaling Profile of Adenosine A
    Moreno E; Chiarlone A; Medrano M; Puigdellívol M; Bibic L; Howell LA; Resel E; Puente N; Casarejos MJ; Perucho J; Botta J; Suelves N; Ciruela F; Ginés S; Galve-Roperh I; Casadó V; Grandes P; Lutz B; Monory K; Canela EI; Lluís C; McCormick PJ; Guzmán M
    Neuropsychopharmacology; 2018 Apr; 43(5):964-977. PubMed ID: 28102227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Δ
    Silveira MM; Adams WK; Morena M; Hill MN; Winstanley CA
    J Psychiatry Neurosci; 2017 Mar; 42(2):131-138. PubMed ID: 28245177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG
    Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons.
    Straiker A; Dvorakova M; Zimmowitch A; Mackie K
    Mol Pharmacol; 2018 Jul; 94(1):743-748. PubMed ID: 29669714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation?
    Zlebnik NE; Cheer JF
    Annu Rev Neurosci; 2016 Jul; 39():1-17. PubMed ID: 27023732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptor expression in non-small cell lung cancer. Effectiveness of tetrahydrocannabinol and cannabidiol inhibiting cell proliferation and epithelial-mesenchymal transition in vitro.
    Milian L; Mata M; Alcacer J; Oliver M; Sancho-Tello M; Martín de Llano JJ; Camps C; Galbis J; Carretero J; Carda C
    PLoS One; 2020; 15(2):e0228909. PubMed ID: 32049991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment.
    Englund A; Morrison PD; Nottage J; Hague D; Kane F; Bonaccorso S; Stone JM; Reichenberg A; Brenneisen R; Holt D; Feilding A; Walker L; Murray RM; Kapur S
    J Psychopharmacol; 2013 Jan; 27(1):19-27. PubMed ID: 23042808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of heteromers formed by cannabinoid CB1, dopamine D2, and adenosine A2A G-protein-coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer.
    Navarro G; Carriba P; Gandía J; Ciruela F; Casadó V; Cortés A; Mallol J; Canela EI; Lluis C; Franco R
    ScientificWorldJournal; 2008 Oct; 8():1088-97. PubMed ID: 18956124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
    McPartland JM; Duncan M; Di Marzo V; Pertwee RG
    Br J Pharmacol; 2015 Feb; 172(3):737-53. PubMed ID: 25257544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption.
    Stern CA; Gazarini L; Vanvossen AC; Zuardi AW; Galve-Roperh I; Guimaraes FS; Takahashi RN; Bertoglio LJ
    Eur Neuropsychopharmacol; 2015 Jun; 25(6):958-65. PubMed ID: 25799920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure.
    Miller S; Daily L; Leishman E; Bradshaw H; Straiker A
    Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5904-5911. PubMed ID: 30550613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.
    Fride E; Ponde D; Breuer A; Hanus L
    Neuropharmacology; 2005 Jun; 48(8):1117-29. PubMed ID: 15910887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.